Literature DB >> 12074640

Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells.

Rania Harfouche1, Haroutioun M Hasséssian, Yang Guo, Valérie Faivre, Coimbatore B Srikant, George D Yancopoulos, Sabah N A Hussain.   

Abstract

The main objective of this study was to identify molecular mechanisms through which angiopoietin-1 (Ang-1), a ligand for Tie-2 receptors, influences endothelial cell apoptosis. Human umbilical vein endothelial cells were cultured in a medium enriched with 2% fetal bovine serum (FBS) and growth supplements. Apoptosis was induced over 24 h by reducing FBS to 0.1%. Activation of caspase-9, -8, -7, and -3 and the expression of Bcl-2 family proteins, inhibitors of apoptosis (IAPs), cytochrome c, as well as Smac proteins were evaluated with immunoblotting. Ang-1 clearly attenuated serum deprivation-evoked apoptosis, an effect which required Tie-2 receptor activation. Activation of caspase-9, -7, and -3, but not caspase-8, was inhibited by Ang-1. The inhibitory effects of Ang-1 on apoptosis and caspase activation were reversed by a PI-3 kinase inhibitor (wortmannin). Ang-1 exposure upregulated the expression of Survivin but not XIAP (members of IAPs), reduced the cystosolic levels of Smac, but not that of cytochrome c, and had no effect on the expression of Bcl-2 family proteins. This is the first study to report on the mitochondrial mechanisms through which Ang-1 inhibits apoptosis and to investigate the role of the newly discovered Smac. We conclude that Ang-1 inhibits endothelial cell apoptosis through several pathways, which include PI-3 kinase/AKT activation, inhibition of Smac release from the mitochondria, and upregulation of Survivin protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074640     DOI: 10.1006/mvre.2002.2421

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  41 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation.

Authors:  Katelyn E Milam; Samir M Parikh
Journal:  Tissue Barriers       Date:  2015-04-03

3.  The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.

Authors:  J S Mohan; P L Lip; A D Blann; D Bareford; G Y H Lip
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 4.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

5.  Signaling and functions of angiopoietin-1 in vascular protection.

Authors:  Nicholas P J Brindle; Pipsa Saharinen; Kari Alitalo
Journal:  Circ Res       Date:  2006-04-28       Impact factor: 17.367

6.  A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke.

Authors:  Judith Mallolas; Rocío Rodríguez; Carme Gubern; Susanna Camós; Joaquín Serena; Mar Castellanos
Journal:  Neuromolecular Med       Date:  2014-10-25       Impact factor: 3.843

7.  Inhibition of human lung adenocarcinoma growth using survivint34a by low-dose systematic administration.

Authors:  Yan Shan; Chunting Wang; Li Yang; Li Juan Chen; Hong Xin Deng; Han Shuo Yang; Zhimian Li; Zhiyong Li; Li Pan; Fei Leng; Yuquan Wei
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

8.  Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation.

Authors:  Xian-bao Liu; Han Chen; Hui-qiang Chen; Mei-fei Zhu; Xin-yang Hu; Ya-ping Wang; Zhi Jiang; Yin-chuan Xu; Mei-xiang Xiang; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2012-08       Impact factor: 3.066

9.  Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation.

Authors:  Edward M Conway; Femke Zwerts; Veerle Van Eygen; Astrid DeVriese; Nobuo Nagai; Wei Luo; Désiré Collen
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  Antitumor effect of mSurvivinThr34→Ala in murine colon carcinoma when administered intravenously.

Authors:  Hong-xia Li; Xin-yu Zhao; Lian Wang; Yong-sheng Wang; Bin Kan; Jian-rong Xu; Jiong Li; Yan-Jun Wen; Xing-chen Peng; Xiang Chen; Fei Yan; Bin Ye; Xiao-bo Du; Ju-mei Zhao; Tao Yi; Xian-cheng Chen; Xiao-xia Du; Yu-quan Wei; Xia Zhao
Journal:  Med Oncol       Date:  2009-12-01       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.